These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 15564288)
1. Polymorphisms in XPD and TP53 and mutation in human lung cancer. Mechanic LE; Marrogi AJ; Welsh JA; Bowman ED; Khan MA; Enewold L; Zheng YL; Chanock S; Shields PG; Harris CC Carcinogenesis; 2005 Mar; 26(3):597-604. PubMed ID: 15564288 [TBL] [Abstract][Full Text] [Related]
2. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer. Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488 [TBL] [Abstract][Full Text] [Related]
3. Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract. Buch S; Zhu B; Davis AG; Odom D; Siegfried JM; Grandis JR; Romkes M Mol Carcinog; 2005 Apr; 42(4):222-8. PubMed ID: 15754315 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers. Gao WM; Romkes M; Siegfried JM; Luketich JD; Keohavong P Mol Carcinog; 2006 Nov; 45(11):828-32. PubMed ID: 16865671 [TBL] [Abstract][Full Text] [Related]
6. [Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing]. Xing DY; Qi J; Tan W; Miao XP; Liang G; Yu CY; Lu WF; Zhou CN; Wu M; Lin DX Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):35-8. PubMed ID: 12579497 [TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Schabath MB; Delclos GL; Grossman HB; Wang Y; Lerner SP; Chamberlain RM; Spitz MR; Wu X Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):878-84. PubMed ID: 15824159 [TBL] [Abstract][Full Text] [Related]
8. Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors. Hou SM; Ryk C; Kannio A; Angelini S; Fält S; Nyberg F; Husgafvel-Pursiainen K Environ Mol Mutagen; 2003; 41(1):37-42. PubMed ID: 12552590 [TBL] [Abstract][Full Text] [Related]
9. ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review. Benhamou S; Sarasin A Am J Epidemiol; 2005 Jan; 161(1):1-14. PubMed ID: 15615908 [TBL] [Abstract][Full Text] [Related]
10. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Spitz MR; Wu X; Wang Y; Wang LE; Shete S; Amos CI; Guo Z; Lei L; Mohrenweiser H; Wei Q Cancer Res; 2001 Feb; 61(4):1354-7. PubMed ID: 11245433 [TBL] [Abstract][Full Text] [Related]
11. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis. Hu Z; Wei Q; Wang X; Shen H Lung Cancer; 2004 Oct; 46(1):1-10. PubMed ID: 15364127 [TBL] [Abstract][Full Text] [Related]
12. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465 [TBL] [Abstract][Full Text] [Related]
13. Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy. Ryu JS; Hong YC; Han HS; Lee JE; Kim S; Park YM; Kim YC; Hwang TS Lung Cancer; 2004 Jun; 44(3):311-6. PubMed ID: 15140544 [TBL] [Abstract][Full Text] [Related]
14. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC Cancer Res; 2002 Mar; 62(5):1377-81. PubMed ID: 11888908 [TBL] [Abstract][Full Text] [Related]
15. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Justenhoven C; Hamann U; Pesch B; Harth V; Rabstein S; Baisch C; Vollmert C; Illig T; Ko YD; Brüning T; Brauch H Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2059-64. PubMed ID: 15598761 [TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma. Yu HP; Wang XL; Sun X; Su YH; Wang YJ; Lu B; Shi LY; Xiong CL; Li YY; Li F; Xu SQ Cancer Genet Cytogenet; 2004 Oct; 154(1):10-5. PubMed ID: 15381366 [TBL] [Abstract][Full Text] [Related]
17. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism. Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995 [TBL] [Abstract][Full Text] [Related]
18. The DNA repair gene ERCC2/XPD polymorphism Arg 156Arg (A22541C) and risk of lung cancer in a Chinese population. Yin J; Li J; Ma Y; Guo L; Wang H; Vogel U Cancer Lett; 2005 Jun; 223(2):219-26. PubMed ID: 15896456 [TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380 [TBL] [Abstract][Full Text] [Related]
20. Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype. Seker H; Butkiewicz D; Bowman ED; Rusin M; Hedayati M; Grossman L; Harris CC Cancer Res; 2001 Oct; 61(20):7430-4. PubMed ID: 11606376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]